Regeneron Pharmaceuticals logo

Manager Biostatistics, Medical Affairs

Regeneron Pharmaceuticals

Tarrytown, NY; Sleepy Hollow, NY; Warren, NJ; Cambridge, MAHybridPosted 2 days ago$131,200 - $214,200/year
Full TimeMid LevelBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Job description

Discover your role

  • Partner with Medical Affairs teams on evidence generation and HTA support.
  • Develop protocols, statistical analysis plans, and analysis methodologies.
  • Collaborate with Statistical Programming on tables, figures, and listings.
  • Analyze clinical trial and non-trial data for program decisions.
  • Prepare presentations and reports for teams, management, and regulators.
  • Advance innovative statistical methods and deliver training to non-statisticians.
  • You bring curiosity to post-hoc analyses and novel evidence-generation approaches.

This role requires

  • PhD in Statistics/Biostatistics with 2+ years of pharmaceutical experience, or MS with 4+ years.
  • Solid knowledge of statistical methodologies, experimental design, and clinical trial design.
  • Ability to code in SAS, R, or Python.
  • Experience designing clinical and observational studies.
  • Experience with machine learning techniques and causal inference methods.
  • Experience developing statistical analysis plans and solving complex statistical problems.
  • Experience creating tables, listings, and figures for publications and presentations.
  • Strong communication skills for technical and non-technical audiences.
  • Ability to collaborate across functions, influence stakeholders, and lead effectively.
  • Ability to manage multiple priorities in a fast-paced environment.
  • Knowledge of life cycle management strategies preferred; drug development knowledge is a plus.

Requirements

  • PhD in Statistics/Biostatistics with 2+ years of pharmaceutical experience, or MS with 4+ years
  • Solid knowledge of statistical methodologies, experimental design, and clinical trial design
  • Ability to code in SAS, R, or Python
  • Experience designing clinical and observational studies
  • Experience with machine learning techniques and causal inference methods
  • Experience developing statistical analysis plans and solving complex statistical problems
  • Experience creating tables, listings, and figures for publications and presentations
  • Strong communication skills for technical and non-technical audiences
  • Ability to collaborate across functions, influence stakeholders, and lead effectively
  • Ability to manage multiple priorities in a fast-paced environment
  • Knowledge of life cycle management strategies preferred
  • Drug development knowledge is a plus

Benefits

  • Annual Bonuses
  • Incentive Plans
  • Equity Awards
  • Pension/Retirement Benefits
  • 401(k) Matching
  • Health & Wellness Programs
  • Fitness Centers
  • Medical, Dental & Vision
  • Paid Time Off
  • Family Support Benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.